Halstead Michael
Insider CIK 1521548 · WCRX Senior V.P., Corp. Development · ITCI SVP and General Counsel · CYBN Chief Executive Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYBN CYBIN INC. | P Buy | 2026-09-21 | 2026-09-21 | 100,000 | $13.47 | $1.35M | 168,568 | SEC↗ |
| CYBN CYBIN INC. | P Buy | 2026-09-21 | 2026-09-21 | 100,000 | $13.47 | $1.35M | 168,568 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 13,134 | — | $0 | 13,134 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 40,472 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 17,916 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 13,133 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 12,240 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 12,240 | — | $0 | 12,240 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 13,134 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 45,454 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 24,478 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer | 2025-04-02 | 2025-04-02 | 21,307 | $132.00 | $2.81M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-10 | 2025-03-10 | 7,345 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-10 | 2025-03-10 | 3,757 | $131.24 | $493.1K | 21,307 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-10 | 2025-03-10 | 7,345 | — | $0 | 25,064 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-06 | 2025-03-10 | 13,133 | — | $0 | 13,133 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-06 | 2025-03-10 | 13,133 | — | $0 | 24,437 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-06 | 2025-03-10 | 6,718 | $131.19 | $881.3K | 17,719 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-01 | 2025-03-04 | 12,239 | — | $0 | 24,478 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-01 | 2025-03-04 | 6,261 | $128.20 | $802.7K | 11,304 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-01 | 2025-03-04 | 12,239 | — | $0 | 17,565 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-02-03 | 2025-02-04 | 45,454 | — | $0 | 45,454 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2025-01-31 | 2025-02-04 | 11,017 | — | $0 | 11,017 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-01-31 | 2025-02-04 | 5,691 | $127.00 | $722.8K | 5,326 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-11-13 | 2024-11-14 | 18,714 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-11-13 | 2024-11-14 | 13,371 | $88.17 | $1.18M | 5,343 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-11-13 | 2024-11-14 | 18,714 | $36.89 | $690.4K | 18,714 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-11-13 | 2024-11-14 | 5,343 | $88.92 | $475.1K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-11-12 | 2024-11-14 | 22,869 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-11-12 | 2024-11-14 | 6,116 | $89.63 | $548.2K | 1,648 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-11-12 | 2024-11-14 | 22,869 | $23.94 | $547.5K | 22,869 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-11-12 | 2024-11-14 | 1,648 | $90.89 | $149.8K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-11-12 | 2024-11-14 | 15,105 | $88.72 | $1.34M | 7,764 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 1,238 | $66.70 | $82.6K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 6,107 | $65.82 | $402.0K | 1,238 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-10 | 2024-03-11 | 7,345 | — | $0 | 7,345 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-10 | 2024-03-11 | 7,345 | — | $0 | 7,345 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 220 | $66.81 | $14.7K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 12,912 | $66.14 | $854.0K | 220 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-06 | 2024-03-08 | 13,132 | — | $0 | 26,266 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-06 | 2024-03-08 | 13,132 | — | $0 | 13,132 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2024-03-01 | 2024-03-05 | 36,717 | — | $0 | 36,717 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 300 | $68.54 | $20.6K | 7,607 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 392 | $70.13 | $27.5K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 7,215 | $69.54 | $501.7K | 392 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-02-23 | 2024-02-27 | 7,907 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-02-23 | 2024-02-27 | 7,907 | — | $0 | 7,907 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 714 | $67.17 | $48.0K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 11,146 | $66.37 | $739.8K | 714 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2024-02-01 | 2024-02-05 | 11,860 | — | $0 | 11,860 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-01-11 | 2024-01-12 | 3,885 | — | $0 | 22,869 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-01-11 | 2024-01-12 | 46,115 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-11 | 2024-01-12 | 18,154 | $66.31 | $1.20M | 31,846 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-11 | 2024-01-12 | 1,486 | $67.80 | $100.8K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-01-11 | 2024-01-12 | 30,360 | $67.10 | $2.04M | 1,486 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-01-11 | 2024-01-12 | 3,885 | $23.94 | $93.0K | 50,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-01-11 | 2024-01-12 | 46,115 | $12.73 | $587.0K | 46,115 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-11-13 | 2023-11-14 | 34,836 | — | $0 | 46,115 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-11-13 | 2023-11-14 | 15,164 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-11-13 | 2023-11-14 | 15,164 | $15.47 | $234.6K | 15,164 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-11-13 | 2023-11-14 | 34,836 | $12.73 | $443.5K | 50,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-11-13 | 2023-11-14 | 8,933 | $53.37 | $476.8K | 41,067 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-11-13 | 2023-11-14 | 41,067 | $54.01 | $2.22M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 476 | $44.15 | $21.0K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 6,868 | $44.99 | $309.0K | 476 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-03-10 | 2023-03-13 | 7,344 | — | $0 | 14,690 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-03-10 | 2023-03-13 | 7,344 | — | $0 | 7,344 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 14,208 | $43.20 | $613.8K | 2,500 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 2,500 | $42.52 | $106.3K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-03-09 | 2023-03-13 | 16,708 | — | $0 | 16,708 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2023-03-06 | 2023-03-08 | 39,398 | — | $0 | 39,398 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-24 | 2023-02-27 | 7,906 | $47.03 | $371.8K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-23 | 2023-02-27 | 7,906 | — | $0 | 7,907 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-23 | 2023-02-27 | 7,906 | — | $0 | 7,906 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 1,100 | $48.68 | $53.5K | 100 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 9,296 | $46.56 | $432.8K | 1,843 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 643 | $47.23 | $30.4K | 1,200 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 100 | $49.60 | $5.0K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-18 | 2023-02-22 | 11,139 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-18 | 2023-02-22 | 11,139 | — | $0 | 11,139 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-12-01 | 2022-12-02 | 50,000 | — | $0 | 15,164 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-12-01 | 2022-12-02 | 22,796 | $53.48 | $1.22M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-12-01 | 2022-12-02 | 50,000 | $15.47 | $773.5K | 50,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-12-01 | 2022-12-02 | 27,204 | $53.94 | $1.47M | 22,796 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 17,916 | — | $0 | 17,916 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 22,034 | — | $0 | 22,034 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 4,188 | $51.62 | $216.2K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 3,718 | $52.38 | $194.7K | 4,188 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-23 | 2022-02-25 | 7,906 | — | $0 | 15,813 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-23 | 2022-02-25 | 7,906 | — | $0 | 7,906 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 4,550 | $54.98 | $250.2K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 6,589 | $55.69 | $366.9K | 4,550 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-18 | 2022-02-23 | 11,139 | — | $0 | 11,139 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-18 | 2022-02-23 | 11,139 | — | $0 | 11,139 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 4,380 | $40.12 | $175.7K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 12,755 | $40.81 | $520.5K | 4,380 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 2,504 | $41.74 | $104.5K | 17,135 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-01-08 | 2022-01-11 | 19,639 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-01-08 | 2022-01-11 | 19,639 | — | $0 | 19,639 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-12-21 | 2021-12-23 | 63,717 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-12-21 | 2021-12-23 | 25,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-12-21 | 2021-12-23 | 88,146 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-12-21 | 2021-12-23 | 4,344 | $44.87 | $194.9K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-12-21 | 2021-12-23 | 25,000 | $13.86 | $346.5K | 25,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-12-21 | 2021-12-23 | 8,690 | $45.74 | $397.5K | 4,344 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-12-21 | 2021-12-23 | 88,146 | $17.57 | $1.55M | 113,146 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-12-21 | 2021-12-23 | 63,717 | $15.73 | $1.00M | 176,863 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-12-21 | 2021-12-23 | 22,620 | $48.62 | $1.10M | 154,243 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-12-21 | 2021-12-23 | 104,775 | $47.84 | $5.01M | 49,468 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-12-21 | 2021-12-23 | 36,434 | $46.87 | $1.71M | 13,034 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 23,719 | — | $0 | 23,719 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 18,714 | — | $0 | 18,714 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 1,100 | $38.91 | $42.8K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 10,039 | $39.28 | $394.3K | 1,100 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-02-18 | 2021-02-22 | 11,139 | — | $0 | 22,278 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-02-18 | 2021-02-22 | 11,139 | — | $0 | 11,139 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-11 | 2021-01-12 | 17,702 | $32.07 | $567.7K | 1,936 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-11 | 2021-01-12 | 1,936 | $31.65 | $61.3K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-01-08 | 2021-01-12 | 19,638 | — | $0 | 19,639 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-01-08 | 2021-01-12 | 19,638 | — | $0 | 19,638 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 3,174 | $30.94 | $98.2K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-04 | 2021-01-05 | 12,986 | $31.39 | $407.6K | 3,174 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-01-03 | 2021-01-05 | 16,160 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-01-03 | 2021-01-05 | 16,160 | — | $0 | 16,160 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-11-17 | 2020-11-19 | 75,000 | — | $0 | 25,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-11-17 | 2020-11-19 | 3,761 | $27.95 | $105.1K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-11-17 | 2020-11-19 | 75,664 | $27.60 | $2.09M | 3,761 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-11-17 | 2020-11-19 | 75,000 | $13.86 | $1.04M | 79,425 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 26,754 | — | $0 | 26,754 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 33,417 | — | $0 | 33,417 | SEC↗ |
| ITCI Intra-Cellular Therapies, | J Other | 2020-01-24 | 2020-01-28 | 3,809 | $23.61 | $89.9K | 4,425 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-01-24 | 2020-01-28 | 8,043 | — | $0 | 8,234 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-09 | 2020-01-10 | 19,638 | $26.16 | $513.7K | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-08 | 2020-01-08 | 19,638 | — | $0 | 39,277 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-08 | 2020-01-08 | 19,638 | — | $0 | 19,829 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-06 | 2020-01-08 | 17,513 | $30.46 | $533.4K | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-06 | 2020-01-08 | 3,945 | $29.80 | $117.6K | 17,704 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-03 | 2020-01-03 | 16,160 | — | $0 | 16,160 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-03 | 2020-01-03 | 5,298 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-03 | 2020-01-03 | 5,298 | — | $0 | 5,489 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-03 | 2020-01-03 | 16,160 | — | $0 | 21,649 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 25 | $34.30 | $857 | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 1,200 | $33.23 | $39.9K | 216 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 4,959 | $32.43 | $160.8K | 1,416 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-01-02 | 2020-01-03 | 1,623 | $31.83 | $51.7K | 6,375 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-12-31 | 2020-01-03 | 7,807 | — | $0 | 7,998 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-08 | 80,951 | — | $0 | 80,951 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-08 | 58,915 | — | $0 | 58,915 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-07 | 2019-01-08 | 3,108 | $12.42 | $38.6K | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-04 | 2019-01-08 | 3,108 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-04 | 2019-01-08 | 5,398 | $11.80 | $63.7K | 3,299 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-04 | 2019-01-08 | 16,060 | $11.34 | $182.1K | 8,697 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-04 | 2019-01-08 | 3,108 | — | $0 | 24,757 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-03 | 2019-01-03 | 16,160 | — | $0 | 32,320 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-01-03 | 2019-01-03 | 5,298 | — | $0 | 5,298 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-03 | 2019-01-03 | 16,160 | — | $0 | 21,649 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-01-03 | 2019-01-03 | 5,298 | — | $0 | 5,489 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-01-02 | 2019-01-03 | 7,807 | $11.09 | $86.6K | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-12-31 | 2019-01-03 | 7,807 | — | $0 | 7,998 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2018-01-22 | 2018-01-24 | 25,500 | $18.03 | $459.8K | 191 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2018-01-05 | 2018-01-05 | 1,560 | $17.49 | $27.3K | 25,691 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2018-01-04 | 2018-01-05 | 3,108 | — | $0 | 3,108 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2018-01-04 | 2018-01-05 | 3,108 | — | $0 | 29,911 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2018-01-04 | 2018-01-05 | 2,660 | $15.75 | $41.9K | 27,251 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2018-01-03 | 2018-01-05 | 5,297 | — | $0 | 10,596 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-01-03 | 2018-01-05 | 65,164 | — | $0 | 65,164 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-01-03 | 2018-01-05 | 48,480 | — | $0 | 48,480 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2018-01-03 | 2018-01-05 | 5,297 | — | $0 | 26,803 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2017-01-05 | 2017-01-09 | 1,601 | $16.55 | $26.5K | 21,506 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2017-01-04 | 2017-01-05 | 3,107 | — | $0 | 6,216 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2017-01-04 | 2017-01-05 | 3,107 | — | $0 | 23,107 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-01-03 | 2017-01-05 | 15,893 | — | $0 | 15,893 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-01-03 | 2017-01-05 | 63,717 | — | $0 | 63,717 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2023-07-07 | 40,472 | — | $0 | 40,472 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2016-01-06 | 9,323 | — | $0 | 9,323 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-01-04 | 2016-01-06 | 39,307 | — | $0 | 39,307 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2015-01-02 | 2015-01-06 | 88,146 | — | $0 | 88,146 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-06 | 2014-11-06 | 13,000 | $15.47 | $201.1K | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2014-11-05 | 2014-11-06 | 7,000 | $15.21 | $106.5K | 7,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2014-07-29 | 2014-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-10-01 | 2013-10-01 | 36,370 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 53,050 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 26,050 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 10,340 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 6,203 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 9,280 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 1,463 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 6,790 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 1,945 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 15,020 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-09-30 | 2013-10-01 | 15,470 | — | $0 | 36,370 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-07-01 | 2013-07-02 | 366 | $19.88 | $7.3K | 51,840 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-28 | 2013-03-01 | 1,747 | $13.46 | $23.5K | 52,206 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-19 | 2013-02-21 | 419 | $14.53 | $6.1K | 53,953 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2013-02-13 | 2013-02-15 | 15,020 | — | $0 | 15,020 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2013-02-13 | 2013-02-15 | 53,050 | — | $0 | 53,050 | SEC↗ |
| WCRX Warner Chilcott plc | A Award | 2013-02-13 | 2013-02-15 | 15,470 | — | $0 | 54,372 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-02-01 | 2013-02-04 | 998 | $14.18 | $14.2K | 38,902 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-01-30 | 2013-01-31 | 320 | $13.38 | $4.3K | 39,900 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-01-22 | 2013-01-23 | 488 | $13.50 | $6.6K | 40,220 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-10-01 | 2012-10-01 | 77 | $13.55 | $1.0K | 40,708 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-07-02 | 2012-07-02 | 355 | $17.96 | $6.4K | 40,785 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-03-01 | 2012-03-02 | 725 | $17.00 | $12.3K | 41,140 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-02-21 | 2012-02-23 | 409 | $16.82 | $6.9K | 41,865 | SEC↗ |
| WCRX Warner Chilcott plc | A Award deriv | 2012-01-31 | 2012-02-02 | 26,050 | — | $0 | 26,050 | SEC↗ |
| WCRX Warner Chilcott plc | A Award | 2012-01-31 | 2012-02-02 | 20,790 | — | $0 | 42,274 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-01-30 | 2012-01-31 | 320 | $16.45 | $5.3K | 21,484 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-01-23 | 2012-01-24 | 487 | $17.32 | $8.4K | 21,804 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2012-01-11 | 2012-01-12 | 452 | $16.66 | $7.5K | 22,291 | SEC↗ |